{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1697803519",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1427672516"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/337970533",
    "http://id.who.int/icd/release/11/2024-01/mms/14808714",
    "http://id.who.int/icd/release/11/2024-01/mms/941488646",
    "http://id.who.int/icd/release/11/2024-01/mms/1697803519/other",
    "http://id.who.int/icd/release/11/2024-01/mms/1697803519/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1697803519",
  "code": "LD2D.1",
  "source": "http://id.who.int/icd/entity/1697803519",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Neurofibromatoses"
  },
  "definition": {
    "@language": "en",
    "@value": "The neurofibromatoses (NF) are related genetic disorders which affect bone, soft tissue, skin and nervous system. In NF type 1 neurofibromas develop in the skin and elsewhere: these can cause problems as a result of their visibility in the skin, compression of vital internal structures or from malignant degeneration. Neuromas of the acoustic nerve are the predominant problem in NF type 2."
  }
}